Alto Neuroscience, Inc. Contracts & Agreements
23 Contracts & Agreements
- Business Finance (8 contracts)
- Business Operations (1)
- Human Resources (7)
- Intellectual Property (5)
- Uncategorized (2)
- Description of Securities (Filed With SEC on March 21, 2024)
- Form of Underwriting Agreement (Filed With SEC on January 29, 2024)
- Form of Common Stock Certificate (Filed With SEC on January 29, 2024)
- 2024 Equity Incentive Plan (Filed With SEC on January 29, 2024)
- Form of Option Grant Notice and Agreement, and Exercise Notice under the 2024 Equity Incentive Plan (Filed With SEC on January 29, 2024)
- Form of RSU Award Grant Notice and Agreement under the 2024 Equity Incentive Plan (Filed With SEC on January 29, 2024)
- 2024 Employee Stock Purchase Plan (Filed With SEC on January 29, 2024)
- Form of Indemnification Agreement between the Registrant and each of its directors and executive officers (Filed With SEC on January 29, 2024)
- Form of Amendment to Employment Offer Letter (Filed With SEC on January 29, 2024)
- Amended and Restated Investor Rights Agreement, by and among the Registrant and certain of its stockholders, dated as of November 20, 2023 (Filed With SEC on January 12, 2024)
- Warrant to Purchase Preferred Stock, dated December 16, 2022, issued to K2 HealthVentures Equity Trust LLC (Filed With SEC on January 12, 2024)
- 2019 Equity Incentive Plan (Filed With SEC on January 12, 2024)
- Form of Option Grant Notice and Agreement, Exercise Notice, Early Exercise Notice, and Restricted Award Notice under the 2019 Equity Incentive Plan (Filed With SEC on January 12, 2024)
- Form of Employment Offer Letter for executive officers (Filed With SEC on January 12, 2024)
- Loan and Security Agreement, by and among the Registrant, K2 HealthVentures LLC, as a lender, and the other lenders from time to time party thereto, or collectively the Lender, K2... (Filed With SEC on January 12, 2024)
- Exclusive License Agreement With Equity, by and between the Registrant and The Board of Trustees of the Leland Stanford Junior University, dated as of December 6, 2019, as amended... (Filed With SEC on January 12, 2024)
- License Agreement, by and between the Registrant and Sanofi, dated as of May 18, 2021 (Filed With SEC on January 12, 2024)
- Patent and Know-How License Agreement, by and between the Registrant and Cerecor Inc. (k/n/a Avalo Therapeutics, Inc.), dated as of May 28, 2021 (Filed With SEC on January 12, 2024)
- Exclusive License Agreement, by and between Dow Agrosciences LLC and Neuralstem, Inc., dated as of December 1, 2016 (Filed With SEC on January 12, 2024)
- Asset Transfer Agreement, by and between the Registrant and Palisade Bio, Inc. (formerly Seneca Biopharma, Inc., formerly Neuralstem Inc.), dated as of October 18, 2021 (Filed With SEC on January 12, 2024)
- Assignment and Assumption Agreement, by and between the Registrant and Palisade Bio, Inc. (formerly Seneca Biopharma, Inc., formerly Neuralstem Inc.), dated as of October 18, 2021 (Filed With SEC on January 12, 2024)
- Asset Purchase Agreement, by and between the Registrant and Teva Pharmaceutical Industries, Ltd., dated as of October 4, 2021 (Filed With SEC on January 12, 2024)
- Joint Development and License Agreement, by and between the Registrant and MedRx Co., Ltd., dated as of September 25, 2023 (Filed With SEC on January 12, 2024)
